1.
Yang M, Zhang W, Yu K, Wang P, Jiang H, Chen L, Meng H, Weng Y, Tao R, Huang X, Xing C, Wang H, Wan J, Wang S, Dai L, Hendrix AY, Xiao J, Wang W, Ma H, Hao S, Jin J, Li Z, Jiang S. A novel BCMA CAR-T-cell therapy with optimized human scFv for treatment of relapsed/refractory multiple myeloma: results from phase I clinical trials. haematol [Internet]. 2022Apr.21 [cited 2022Aug.18];107(8):1960-5. Available from: https://haematologica.org/article/view/haematol.2022.280629